Spectrum Pharmaceuticals, Inc. Message Board
- Reply to
Fine Day to Cover Before CHMP - Just 2 Trading Days to go
by fezziwig2008 •May 23, 2013 9:35 AMPump and Pump? Time to dump.
Sentiment: Strong Sell
-
Never :)
Sentiment: Strong Sell
-
Cash grew by 20M and they wrote off AR worth nearly 60M. Have fun and keep counting the chickens before they are .... Raj is incubating them nicely for you. With 30M of AR remaining we will see how he manipulates the numbers in the next Q. 50% of the Docs have not been called - is a weak statement to make. Raj and KK both know those Oncs are never going to write Fusilev Rx, it is a hog wash and BS, it is time they come out clean and admit the sales are not as robust as they expected (again), it will happen. Spectrum will pay a small fine to SEC and that will be the end of it - keep evaporating the cash. If they admit to any wrong doing, the laywers will eat them for lunch and SPPI will be trading like AFFY with or without pipeline.
Sentiment: Strong Sell
-
He knows - that is a f ing joke.
Sentiment: Strong Sell
-
Bulk of the cash was raised by wiping off the AR number, we will see how the sales track in the next Q. POS SPPI is going to crash and burn. Shorting more - thank you for bidding it up.
Sentiment: Strong Sell
- Reply to
ANTISENSE how does it feel shorting 76k shares at little over $7,
by thecomforter1919 •May 9, 2013 9:41 AMUp? What up? Do you see any green? We will see who is the genius. I will cover when we see $3 print. Until then keep smoking the stuff....
Sentiment: Strong Sell
-
PCTL Market too small for both Folotyn and Belinostat. Belinostat is approved will cannibalize Folotyn revenue.
Melphalan is a dud drug.
Apaziquone is another dud.
Zevalin is really selling right?
What else is near term?
Anyone look at the earnings release? Cover up the bad news with the good NDA submission headlines.
Make up the numbers using ARs, how much write down is coming in the next Q - we will see.
Raj is desperate to print something good. Lipstick on a pig. POS is going down.Sentiment: Strong Sell
- Reply to
ANTISENSE how does it feel shorting 76k shares at little over $7,
by thecomforter1919 •May 9, 2013 9:41 AMHopefully you are right. Keep buying more.
Sentiment: Strong Sell
-
Hurry get your calculator out and smoke the stuff Raj is handing out.
Sentiment: Strong Sell
- Reply to
ANTISENSE how does it feel shorting 76k shares at little over $7,
by thecomforter1919 •May 9, 2013 9:41 AMBuy some more so I can short a bit more. Lipstick on a pig is what this report is all about.
Sentiment: Strong Sell
-
I will feel very very sad for you and at some point you would want to sue Raj and Co. like I do but you will not be able to do so, because you will not in the class action window. Personally, I would like nothing more than Raj to get fired tomorrow. Yes, the only way SPPI traders higher than 7 tomorrow is if Raj steps down, but it will not happen. I would go long Spectrum if Raj and KK both resign immediately.
Sentiment: Strong Sell
- Reply to
I'll tell you why I wouldn't sell SPPI at these levels.
by biotechtrader2012 •May 8, 2013 3:28 PMGood luck to you Sherry, I wish you had dumped the stock when you had a chance. Last Q the stock went from a low of $10 (few days before earnings) to 12.50 the day before earnings and I was hopeful it would lead to a short squeeze should the numbers come in really strong. It was wishful thinking, now a Q has passed and Raj and Co. have had no Conferences since the special conf. after the new revenue guidance. It is a great opportunity for the analysts to ask serious questions about Fusilev. No one is considering anything other than that in the pipeline at the moment. I think even RIGL is a better bet than Spectrum at this stage thanks to their cash and despite a failed PIII because the investors have hope of 2 more PIIIs and the stock is trading near cash. Spectrum on the other hand is depleting cash at a faster pace thanks to the great sales force who have not called on 50% of the Oncs who MAY prescribe Fusilev. Unless Spectrum starts to bribe them they are not likely to write those Rxs, unfortunately Fusilev is not a big drug and Spectrum does not have deep pockets to bribe anyone.
Hope you wise up and dump this and move on, you will be able to buy Spectrum for its pipeline at a much lower price point in the near future. Thanks to Raj and dumb KK and his team, I have lost big in terms of paper profit on Spectrum. I was a believer like you and you can go back and see my messages from the past. Including insults to PK.Sentiment: Strong Sell
-
Apaziquone is DOA Raj has to stop giving you hope because it is taking shareholders on another joy ride.
Sentiment: Strong Sell
- Reply to
I'll tell you why I wouldn't sell SPPI at these levels.
by biotechtrader2012 •May 8, 2013 3:28 PMYou call yourself a biotechtrader? You are so right dude, now take your 10 shares and shut the #$%$ k up. I have been long Spectrum since 2009 before Zevalin got approval for first line therapy and before Fusilev got a CRL. So, think again when I was long, I did believe all the BS Raj threw at us, only I woke up when he dropped the bomb 2 weeks after last q earnings. In less than 2 weeks he dropped the revenue guidance 40% and I suspect the number is still too large and in the next 2-3 qtrs he will drop it down to $140M or lower. Shorts are not going to cover unless this POS goes to $3. I will be a buyer for the pipeline at or around $3 nothing before than and I will be loading up on Spectrum when you will be crying for not having dumping your long when you could.
Except for one person on this board PK who has consistently been cautioning about Raj - no one has had vision to see through Raj and Co.Sentiment: Strong Sell
-
How to you know it is better than Neulesta? Because Raj told you so? Where the f is Apaziquone PIII data? Have you looked at it yet? They keep saying the same #$%$ but are doing a new PIII trial. New drug they licensed is another dud - you really think any Co. would out license a drug for $3M upfront payment. You get what you paid for.
BTW: Person who is so smart in thinking I am from Bangladesh and am getting paid 10c/message should know I had more shares in Spectrum than most insiders and I dumped it all because Raj and KK are taking shareholders for a joy ride. I am shorting as many shares I can get my hands onto because this #$%$ is going down further. 22M shares are still short and increasing none of these shorts are going away. Drop from $12.50 to $8 did not make them cover so all the smart longs on this board need to think why these shorts are not covering? Raj may print a $15M number for Fusilev for this Q and even with 15M the total for the three products will not exceed $40M. So, at most they can make $160M which is still lover than the guidance. I don't know how many folks have been here since FDA first allowed Fusilev to be sold w/o approval, few qtrs after that the sales for Fusilev dropped from $20M/qtr to 300K/qtr because there was sufficient supply of leucovorin. I do not think sales will drop down to 300K/qtr, but they are not going to be higher than 10M/qtr either. At which point total sales would not exceed 35M/qtr.
In terms of EPS number, watch the SG&A costs which are increasing thanks to the overly generous pay package of KK and his team.Sentiment: Strong Sell
- Reply to
We all have our own agenda sppi has a great business model
by hneiman •May 8, 2013 10:12 AMDreaming of whatever Raj sold them on, I am guilty of the same crime until he dropped the last bomb. I am awake now, but lot of folks here are still dreaming of $17 - never going to happen.
I just hope Raj does not drop the bomb on them and if Folotyn comes in weaker than expected - all hell will break lose on this #$%$. I think Fusilev sales will come in under 15M for the Q only due to backlog. Lots of channel stuffing going on. Adam will be out in full force tomorrow beating the #$%$ of anything Raj says. Next 3 days this POS will be touching $4. Tried shorting 100K shares today, could not get a fill - not enough inventory. I did get 76K shares though.Sentiment: Strong Sell
-
Of course feezweed was there to ask a dumb question. Sinking like a stone in 2 weeks, nothing new for 6 weeks. RIP until then or as I say it crash and burn.
Sentiment: Strong Sell
-
3 FDA approved drugs. One tending to 0. Other barely doing 8M/qtr for nearly 4 years now, folotyn only hope of doing 15m/qtr. 3 Upcoming FDA - which ones? Belinostat will cannibalize on Folotyn sales - total PCTL market is 180M and competes with Istodax. Apaziquone is a dud. 10 Drugs are far out - we will see how things pan out for those 10 drugs.
Sentiment: Strong Sell
-
I hope Raj does not take down the guidance from $180 to $100M.
I am out of this stock but watching, for the promise of other drugs but the valuation gives me pause and there is the 22M short interest which is a constant overhang. Shorts want this to go to $3 and I think they will succeed because Raj and Ken have no credibility.Sentiment: Strong Sell
- Reply to
57% Analysts Rate HALO a Buy- Increasing over 3 Months- Forbes 5/6/13
by fezziwig2008 •May 7, 2013 3:00 PMEveryone has access to Yahoo, google and Bing and clinicaltrials.gov, Baxter, Viropharma, Roche and other press releases and can search whatever they need to. So what value do you add by your constant barrage of recycled #$%$? Whatever bullish thing you are smoking does not seem to be working on the rest of the folks here.
STOP POSTING #$%$Sentiment: Strong Sell